Pneumonia hospitalizations and mortality in children 3 – 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)

Pneumococcal conjugate vaccine ten valent (PCV 10) was introduced into Nigeria in three phases. Phase 3 introduction started in August 2016. However, its impact on pneumonia admissions and mortality among vaccinated Nigerian children has not been determined. Data in the period before PCV-10 introduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iliya, Jalo, Shatima, Denis R., Tagbo, Beckie N., Ayede, Adejumoke I., Fagbohun, Abieyuwa O., Rasaq, Aliu, Nalban, Sarah, Elon, Isaac W., Mohammed-Nafiu, Ramatu, Ahmed, Patience, Oyewole, Oladapo B., Bakare, Ayobami A., Yusuf, Bidemi O., Akinrinoye, Olugbenga O., Ogala, William N., Falade, Adegoke G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Pneumococcal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980440/
https://www.ncbi.nlm.nih.gov/pubmed/36597576
http://dx.doi.org/10.1080/21645515.2022.2162289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980440/
https://www.ncbi.nlm.nih.gov/pubmed/36597576
http://dx.doi.org/10.1080/21645515.2022.2162289

Ejemplares similares